BioCentury
ARTICLE | Clinical News

Peanut Allergy Oral Immunotherapy: Phase IIb started

March 10, 2014 7:00 AM UTC

Allergen Research began a double-blind, placebo-controlled, U.S. Phase IIb trial to evaluate the company's Peanut Allergy OIT in about 55 peanut-allergic subjects ages 4-26 years. The trial will follo...